USE OF A PHOSPHOLIPID EMULSION CONTAINING AN EFFECTIVE AMOUNT OF DIHYDROQUERCETIN, LECITHIN AND GLYCINE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY SYSTEM Russian patent published in 2021 - IPC A61K9/20 A61K9/72 A61K31/198 A61K31/352 A61K31/683 A61P11/00 A61P29/00 A61P31/14 

FIELD: medicine.

SUBSTANCE: invention relates to the field of medicine, in particular to pulmonology, and is intended for the auxiliary treatment of inflammatory diseases of the respiratory organs. For the treatment of inflammatory diseases of the respiratory system in patients with moderate and mild COVID-19, a phospholipid emulsion containing dihydroquercetin, lecithin and glycine is used as auxiliary therapy. The components are used in the declared quantities.

EFFECT: use of the invention makes it possible to increase the effectiveness of relieving the symptoms of inflammatory diseases of the respiratory system, normalize the patient’s condition, reduce the risks of complications and deterioration of health in this pathology.

6 cl, 2 tbl